beijing tong ren tang chinese medic - BJTRF

BJTRF

Close Chg Chg %
1.50 -0.85 -56.77%

Closed Market

0.65

-0.85 (56.77%)

Volume: 800.00

Last Updated:

Apr 1, 2024, 9:30 AM EDT

Company Overview: beijing tong ren tang chinese medic - BJTRF

BJTRF Key Data

Open

$0.65

Day Range

0.65 - 0.65

52 Week Range

0.65 - 1.50

Market Cap

$544.12M

Shares Outstanding

837.10M

Public Float

236.30M

Beta

0.27

Rev. Per Employee

N/A

P/E Ratio

8.46

EPS

$0.08

Yield

650.89%

Dividend

$0.04

EX-DIVIDEND DATE

Jun 3, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

BJTRF Performance

No Data Available

BJTRF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About beijing tong ren tang chinese medic - BJTRF

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. It operates through the following geographical segments: Hong Kong, Mainland China and Overseas. The Hong Kong segment sells Chinese medicine and healthcare products and provides medical consultation and treatments through retail outlets, as well as wholesale in Hong Kong. The Mainland China segment engages in the wholesale of healthcare products in the Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside the Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments in other overseas countries/regions, including Macao. The company was founded in 1669 and is headquartered in Hong Kong.

BJTRF At a Glance

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Room 1405-1409, Office Tower
Hong Kong,
Phone 852-3657-5819 Revenue 206.54M
Industry Pharmaceuticals: Major Net Income 64.11M
Sector Health Technology 2024 Sales Growth 6.037%
Fiscal Year-end 12 / 2025 Employees 782
View SEC Filings

BJTRF Valuation

P/E Current 8.465
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 14.756
Price to Sales Ratio 4.581
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 8.871
Enterprise Value to Sales 3.63
Total Debt to Enterprise Value 0.021

BJTRF Efficiency

Revenue/Employee 264,120.989
Income Per Employee 81,987.04
Receivables Turnover 3.05
Total Asset Turnover 0.357

BJTRF Liquidity

Current Ratio 16.85
Quick Ratio 10.099
Cash Ratio 7.732

BJTRF Profitability

Gross Margin 66.102
Operating Margin 35.453
Pretax Margin 38.949
Net Margin 31.041
Return on Assets 11.072
Return on Equity 12.574
Return on Total Capital 11.861
Return on Invested Capital 12.354

BJTRF Capital Structure

Total Debt to Total Equity 3.028
Total Debt to Total Capital 2.939
Total Debt to Total Assets 2.707
Long-Term Debt to Equity 1.618
Long-Term Debt to Total Capital 1.57
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Beijing Tong Ren Tang Chinese Medic - BJTRF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
200.20M 221.07M 194.78M 206.54M
Sales Growth
+18.05% +10.42% -11.89% +6.04%
Cost of Goods Sold (COGS) incl D&A
57.21M 82.39M 70.09M 70.01M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
9.00M 9.64M 10.54M 11.29M
Depreciation
8.71M 9.23M 10.11M 10.85M
Amortization of Intangibles
290.11K 404.57K 429.56K 440.60K
COGS Growth
+18.45% +44.01% -14.92% -0.11%
Gross Income
143.00M 138.69M 124.69M 136.53M
Gross Income Growth
+17.89% -3.01% -10.09% +9.49%
Gross Profit Margin
+71.43% +62.73% +64.02% +66.10%
2021 2022 2023 2024 5-year trend
SG&A Expense
43.87M 36.27M 45.99M 63.30M
Research & Development
1.45M 983.21K 1.56M 1.17M
Other SG&A
42.42M 35.29M 44.43M 62.13M
SGA Growth
+14.67% -17.31% +26.79% +37.64%
Other Operating Expense
- - - -
-
Unusual Expense
- - (62.14K) (11.49K)
-
EBIT after Unusual Expense
99.19M 102.42M 78.70M 73.23M
Non Operating Income/Expense
1.52M 3.85M 10.33M 8.05M
Non-Operating Interest Income
563.11K 2.63M 9.31M 7.34M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
605.57K 595.24K 763.58K 830.58K
Interest Expense Growth
+9.23% -1.71% +28.28% +8.78%
Gross Interest Expense
605.57K 595.24K 763.58K 830.58K
Interest Capitalized
- - - -
-
Pretax Income
100.11M 105.68M 88.27M 80.45M
Pretax Income Growth
+13.06% +5.56% -16.47% -8.86%
Pretax Margin
+50.00% +47.80% +45.32% +38.95%
Income Tax
16.32M 17.20M 12.42M 12.89M
Income Tax - Current - Domestic
- 17.29M 16.33M 15.12M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (972.36K) 863.93K (2.70M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
83.82M 88.28M 75.44M 67.82M
Minority Interest Expense
5.62M 5.80M 6.41M 3.70M
Net Income
78.20M 82.48M 69.03M 64.11M
Net Income Growth
+11.81% +5.48% -16.32% -7.12%
Net Margin Growth
+39.06% +37.31% +35.44% +31.04%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
78.20M 82.48M 69.03M 64.11M
Preferred Dividends
- - - -
-
Net Income Available to Common
78.20M 82.48M 69.03M 64.11M
EPS (Basic)
0.0934 0.0985 0.0825 0.0766
EPS (Basic) Growth
+11.72% +5.46% -16.24% -7.15%
Basic Shares Outstanding
837.10M 837.10M 837.10M 837.10M
EPS (Diluted)
0.0934 0.0985 0.0825 0.0766
EPS (Diluted) Growth
+11.72% +5.46% -16.24% -7.15%
Diluted Shares Outstanding
837.10M 837.10M 837.10M 837.10M
EBITDA
108.13M 112.05M 89.24M 84.52M
EBITDA Growth
+16.17% +3.62% -20.36% -5.29%
EBITDA Margin
+54.01% +50.69% +45.82% +40.92%

Beijing Tong Ren Tang Chinese Medic in the News